Trials Offered by a Specific Doctor
HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Dr. Ran Reshef
212-342-0530
rr3036@columbia.edu
(Biography not available)
Clinical Studies Managed By Dr. Reshef:
| More Info | Title | Sponsor | IRB Number |
|---|---|---|---|
| Details | A study for patients with lymphomas using EBV-Cytotoxic T Lymphocytes (EBV-CTLs) | Atara | AAAR0039 |
| Details | A study for patients with chronic Graft Versus Host Disease (cGVHD) using study drug Ibrutinib | Pharmacyclics LLC. | AAAR1134 |